Lexology December 1, 2022
Click here to listen to the audio
In this Ropes & Gray podcast, health care partners Margaux Hall and Stephanie Webster and counsel David Ault explore drug pricing reforms and limits on agency action. In the months leading up to the midterm elections, we saw a flurry of activity around drug pricing, and now, in the wake of midterms, we see heightened bipartisan interest in the topic. Listen in to hear about some of the key recent events and a discussion on the fundamental question of how far agencies can go in regulating drug pricing.
Transcript:
Margaux Hall: Hello, everyone, and welcome to this podcast. Today, we will be discussing drug pricing reforms and limits on agency action. In the...